Tianlin Sun

Tianlin Sun practices at Northwestern Catherine Gratz Griffin Lake Forest Hospital in Lake Forest, Illinois.

Tianlin Sun's NPI, 1336602481, was assigned on April 7, 2019. Tianlin Sun graduated from University of Texas Medical School at Houston in 2019. Tianlin Sun holds Illinois license 036159021.

Tianlin Sun's primary practice is Northwestern Catherine Gratz Griffin Lake Forest Hospital, at 1000 N Westmoreland Rd, Lake Forest, IL 60045 in Lake County. The practice phone is (847) 234-5600.

Tianlin Sun's primary practice is Northwestern Catherine Gratz Griffin Lake Forest Hospital in Lake Forest, Illinois. Tianlin Sun is also affiliated with Northwestern Medicine Catherine Gratz Griffin Lake Forest Hospital. The medical group on file is Northwestern Medical Faculty Foundation. Dmand AI also links Tianlin Sun to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Tianlin Sun practices, 3 sites in all. Vendor and product names are available with a free account.

Hospitalist is Tianlin Sun's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Tianlin Sun is licensed in Illinois.

CMS data shows 583 Medicare services from Tianlin Sun across 6 procedure codes in 2024, for 314 Medicare patients. Medicare paid $58,903 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 314 Medicare patients who saw Tianlin Sun in 2024. The largest group is 75 to 84, with 123 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 2.39, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Tianlin Sun's median patient age at 72, with 58% women.

In 2024, Tianlin Sun wrote 200 Medicare Part D claims for 71 patients. 85% of them were for generic drugs. CMS names the drug for 45 of them, across 3 drugs with 11 or more claims each, at $649 in total drug cost. In 2023, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Tianlin Sun for performance year 2024, reported through an alternative payment model (APM). Tianlin Sun accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Tianlin Sun, published from 2013 to 2016. Tianlin Sun's most frequent co-author is Yun Gong, MD.

Tianlin Sun graduated from University of Texas Medical School at Houston in 2019.